Intuitive Surgical, Inc. $ISRG Shares Acquired by Signal Advisors Wealth LLC

Signal Advisors Wealth LLC raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 21.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,112 shares of the medical equipment provider’s stock after buying an additional 1,415 shares during the quarter. Signal Advisors Wealth LLC’s holdings in Intuitive Surgical were worth $4,594,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of ISRG. Holos Integrated Wealth LLC purchased a new stake in Intuitive Surgical in the 4th quarter valued at approximately $25,000. Kilter Group LLC purchased a new position in Intuitive Surgical during the second quarter worth about $27,000. Greykasell Wealth Strategies Inc. acquired a new stake in shares of Intuitive Surgical during the 3rd quarter worth $27,000. Olistico Wealth LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth $28,000. Finally, Caitlin John LLC acquired a new stake in shares of Intuitive Surgical in the third quarter valued at about $30,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Down 0.4%

NASDAQ:ISRG opened at $469.98 on Thursday. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $603.88. The firm has a market cap of $166.90 billion, a PE ratio of 59.57, a price-to-earnings-growth ratio of 3.64 and a beta of 1.66. The company’s 50-day moving average price is $497.60 and its two-hundred day moving average price is $513.35.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. During the same period in the prior year, the company posted $2.21 EPS. The company’s revenue was up 18.8% compared to the same quarter last year. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 133 shares of the firm’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $65,829.68. Following the completion of the transaction, the vice president directly owned 660 shares in the company, valued at $326,673.60. This trade represents a 16.77% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Patricia L. Wadors sold 220 shares of Intuitive Surgical stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $499.71, for a total value of $109,936.20. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 32,943 shares of company stock worth $17,279,568. Corporate insiders own 0.60% of the company’s stock.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Wall Street analysts remain broadly constructive on ISRG, with the average brokerage recommendation favoring buy/hold and continued sell‑side support that can underpin demand for the shares. Wall Street Analysts Think Intuitive Surgical (ISRG) Is a Good Investment: Is It?
• Positive Sentiment: Strategic expansion: ISRG is taking direct control of da Vinci and Ion distribution in Southern Europe, aiming to improve system availability, service and hospital access — a move that can drive recurring revenue and tighter customer relationships in a key geography. Intuitive Surgical Extends Southern Europe Reach As Stock Trades Below Targets
• Neutral Sentiment: Margins and tariff headwinds: Q4 margin compression was noted (margins ~37%), but management offset some pressure via cost efficiencies and strong recurring revenue — this tempers the near‑term outlook while leaving long‑term profitability intact if cost actions hold. ISRG’s Margins Contract in Q4: Will Tariffs Continue to Hurt in 2026?
• Neutral Sentiment: Investor attention and stock trend pieces are increasing visibility on ISRG (more searches and “trending” writeups), which can boost liquidity but also amplify volatility as opinion pieces circulate. Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
• Neutral Sentiment: Short‑interest reporting appears inconsistent in recent feeds (large reported increases but values show zero/NaN); this data should be treated cautiously until confirmed by exchange filings. (No reliable link available.)
• Negative Sentiment: Recent share weakness: ISRG has underperformed recently (shares have moved lower vs. the market), and periodic selloffs amplify short‑term downside risk while investors wait for clearer signs that tariff and margin headwinds have stabilized. Intuitive Surgical, Inc. (ISRG) Suffers a Larger Drop Than the General Market: Key Insights

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. Robert W. Baird decreased their price target on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a research note on Friday, January 23rd. TD Cowen raised Intuitive Surgical to a “strong-buy” rating in a report on Tuesday, January 27th. UBS Group decreased their target price on shares of Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a research note on Tuesday, March 17th. Wells Fargo & Company raised their price objective on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Finally, Argus cut their price objective on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $614.95.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.